Medwaala Pharmaceuticals Private Limited

Medwaala Pharmaceuticals Private Limited - healthcare in Delhi North East, Delhi, India. FY 2026 financials and compliance.
CIN U33119DL2017PTC310008 Incorporated 02 January 2017 ROC Delhi HQ Delhi North East, Delhi, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2024
₹57.45 Lakh
▲ 15.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Last financials
Mar 2025
Balance sheet date

About Medwaala Pharmaceuticals Private Limited

Data last updated: 24 February 2026

Medwaala Pharmaceuticals Private Limited is a private limited company based in Delhi North East, Delhi, India, recognised as a startup by DPIIT. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 02 January 2017, the company has been in operation for over 9 years.

Registered with ROC Delhi under CIN U33119DL2017PTC310008.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gurpreet Kaur and Gurmeet Singh.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 19 F/F, Kh.No – 30/2 Main Wazirabad Road Brij Puri, Delhi North East, Delhi, India – 110094.

As per the financials filed for FY 2024, the company reported a revenue of ₹57.45 Lakh, a growth of 15% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medwaala.com.

Company Details of Medwaala Pharmaceuticals Private Limited
CIN U33119DL2017PTC310008
Registration Number 310008
Incorporation Date 02 January 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    A – 19 F/F, Kh.No – 30/2 Main Wazirabad Road Brij Puri, Delhi North East, Delhi, India – 110094
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Company report
Medwaala Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Medwaala Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Medwaala Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Medwaala Pharmaceuticals Private Limited

Medwaala Pharmaceuticals Private Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G2 Retail Trading Locked
Premium access

Business activity turnover details for Medwaala Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Medwaala Pharmaceuticals Private Limited

Medwaala Pharmaceuticals Private Limited is currently managed by 2 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Gurpreet Kaur Director 21 Feb 2020 6 Years 5 Months Current
Gurmeet Singh Director 02 Jan 2017 9 Years 6 Months Current

Financials of Medwaala Pharmaceuticals Private Limited FY 2025 filings available

Medwaala Pharmaceuticals Private Limited reported revenue of ₹57.45 Lakh (up 15.00% YoY) for FY 2024.

Revenue · FY 2024
₹57.45 Lakh ▲ 15.00%
Premium access

Ten-year financial statements for Medwaala Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Medwaala Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Medwaala Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Medwaala Pharmaceuticals Private Limited

Medwaala Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Medwaala Pharmaceuticals Private Limited

View historical data on people associated with Medwaala Pharmaceuticals Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Medwaala Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Medwaala Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Medwaala Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Medwaala Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Medwaala Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Medwaala Pharmaceuticals Private Limited

Premium access

MSME payment history for Medwaala Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Medwaala Pharmaceuticals Private Limited

Premium access

Corporate group structure for Medwaala Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Medwaala Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Medwaala Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Medwaala Pharmaceuticals Private Limited

Activity
30 Sep 2025
Medwaala Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Medwaala Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Directors
21 Feb 2020
Gurpreet Kaur was appointed as a Director on 21 Feb 2020 & has been associated with this company since 6 years 5 months.
Directors
02 Jan 2017
Gurmeet Singh was appointed as a Director on 02 Jan 2017 & has been associated with this company since 9 years 6 months.
Activity
02 Jan 2017
Medwaala Pharmaceuticals Private Limited was registered on 02 Jan 2017 with Roc Delhi Ii & aged 9 years 6 months as per MCA records.

Frequently Asked Questions about Medwaala Pharmaceuticals Private Limited

Medwaala Pharmaceuticals Private Limited is an active private limited company in the healthcare sector based in Delhi North East, Delhi, India. It was incorporated on 02 January 2017 (9+ years old) and is registered under CIN U33119DL2017PTC310008.

Medwaala Pharmaceuticals Private Limited reported revenue of ₹57.45 Lakh for FY 2024 (up 15.00% YoY).

The current directors of Medwaala Pharmaceuticals Private Limited are:

The primary industry of Medwaala Pharmaceuticals Private Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.

Yes, Medwaala Pharmaceuticals Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Medwaala Pharmaceuticals Private Limited can be reached at the registered office: A – 19 FF, Kh.No – 302 Main Wazirabad Road Brij Puri, Delhi North East, Delhi, India – 110094, or through the website medwaala.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available